Acute lymphoblastic leukaemia (ALL) is a haematological malignancy characterized by the
uncontrolled proliferation of immature lymphoid cells. Over past decades, significant …

Working groups of the European LeukemiaNet have published several important consensus
guidelines. Acute lymphoblastic leukemia (ALL) has many different clinical and biological …

UBTF tandem duplications (UBTF-TDs) have recently emerged as a recurrent alteration in
pediatric and adult acute myeloid leukemia (AML). UBTF-TD leukemias are characterized by …

Abstract Current classifications (World Health Organization-HAEM5/ICC) define up to 26
molecular B-cell precursor acute lymphoblastic leukemia (BCP-ALL) disease subtypes by …

Distinct diagnostic entities within BCR:: ABL1-positive acute lymphoblastic leukemia (ALL)
are currently defined by the International Consensus Classification of myeloid neoplasms …

Transcription/processing of the ribosomal RNA (rRNA) precursor, as part of ribosome
biosynthesis, is intensively studied and characterized in eukaryotic cells. Here, we …

Introduction The malignant transformation leading to a maturation arrest in B-cell precursor
acute lymphoblastic leukemia (BCP-ALL) occurs early in B-cell development, in a pro-B or …

In contrast to B-cell precursor acute lymphoblastic leukemia (ALL), molecular subgroups are
less well defined in T-lineage ALL. Comprehensive studies on molecular T-ALL subgroups …

B‐acute lymphoblastic leukaemia (B‐ALL) is a haematological disease resulting from
haematopoietic system dysfunction, leading to the unchecked growth of immature B …

B‐cell acute lymphoblastic leukemia (B‐ALL), a genetically heterogeneous disease, is
classified into different molecular subtypes that are defined by recurrent gene …